SHANK2 and renal cell carcinoma: Furthermore, our pooled analysis of 19 independent studies revealed that the mRNA expression of SHANK2 was downregulated in RCC compared with that in adjacent normal tissues, and lower expression levels of SHANK2 were significantly associated with poorer survival of patients with RCC.